Development and validation of a nomogram prognostic model for esophageal cancer patients with oligometastases
2020 · Scientific Reports · 28 citations
https://doi.org/10.1038/s41598-020-68160-6
B
Butuo Li
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
62
Papers
547
Citations
15
h-index
20
i10-index
Butuo Li is an academic researcher from Shandong First Medical University. The author has contributed to research in topics: Lung Cancer Diagnosis and Treatment & Lung Cancer Research Studies & Cancer Immunotherapy and Biomarkers. The author has an h-index of 15, co-authored 53 publications.
ORCID: 0000-0002-1849-3435Papers by this author
worksFrom pixels to patient care: deep learning-enabled pathomics signature offers precise outcome predictions for immunotherapy in esophageal squamous cell cancer
2024 · Journal of Translational Medicine · 22 citations
https://doi.org/10.1186/s12967-024-04997-z
Multidimensional comparative evaluation of first-line therapies for extensive-stage small cell lung cancer: a systematic review and network meta-analysis of clinical efficacy and safety profiles
2025 · BMC Cancer · 1 citations
https://doi.org/10.1186/s12885-025-14750-4
Maximizing survival benefit with precision therapy based on progressive patterns after immunochemotherapy in metastatic esophageal cancer
2025 · iScience · 0 citations
https://doi.org/10.1016/j.isci.2025.114188
Combining evidence and practice: evaluating proton re-irradiation in recurrent lung cancer
2026 · International Journal of Radiation Biology · 0 citations
https://doi.org/10.1080/09553002.2026.2630994
Combining evidence and practice: evaluating proton re-irradiation in recurrent lung cancer
2026 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.31378422
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat